Imperial College London
Portrait Picture

ProfessorMarisaMiraldo

Business School

Professor in Health Economics and Policy
 
 
 
//

Contact

 

m.miraldo Website CV

 
 
//

Location

 

418Business School BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Simmons:2021:10.2471/blt.20.270934,
author = {Simmons, B and Ariyoshi, K and Ohmagari, N and Pulcini, C and Huttner, B and Gandra, S and Satta, G and Moja, L and Sharland, M and Magrini, N and Miraldo, M and Cooke, G},
doi = {10.2471/blt.20.270934},
journal = {Bulletin of the World Health Organization},
pages = {550--561},
title = {Progress towards antibiotic use targets in eight high-income countries},
url = {http://dx.doi.org/10.2471/blt.20.270934},
volume = {99},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objective To compare antibiotic sales in eight high-income countries using the 2019 World Health Organization (WHO) Access, Watch andReserve (AWaRe) classification and the target of 60% consumption of Access category antibiotics.Methods We analysed data from a commercial database of sales of systemic antibiotics in France, Germany, Italy, Japan, Spain, Switzerland,United Kingdom of Great Britain and Northern Ireland, and United States of America over the years 2013–2018. We classified antibioticsaccording to the 2019 AWaRe categories: Access, Watch, Reserve and Not Recommended. We measured antibiotic sales per capita in standardunits (SU) per capita and calculated Access group sales as a percentage of total antibiotic sales.Findings In 2018, per capita antibiotic sales ranged from 7.4 SU (Switzerland) to 20.0 SU (France); median sales of Access group antibioticswere 10.9 SU per capita (range: 3.5–15.0). Per capita sales declined moderately over 2013–2018. The median percentage of Access groupantibiotics was 68% (range: 22–77 %); the Access group proportion increased in most countries between 2013 and 2018. Five countriesexceeded the 60% target; two countries narrowly missed it (>55% in Germany and Italy). Sales of Access antibiotics in Japan were low(22%), driven by relatively high sales of oral cephalosporins and macrolides.Conclusion We have identified changes to prescribing that could allow countries to achieve the WHO target. The 60% Access group targetprovides a framework to inform national antibiotic policies and could be complemented by absolute measures and more ambitious valuesin specific settings.
AU  - Simmons,B
AU  - Ariyoshi,K
AU  - Ohmagari,N
AU  - Pulcini,C
AU  - Huttner,B
AU  - Gandra,S
AU  - Satta,G
AU  - Moja,L
AU  - Sharland,M
AU  - Magrini,N
AU  - Miraldo,M
AU  - Cooke,G
DO  - 10.2471/blt.20.270934
EP  - 561
PY  - 2021///
SN  - 0042-9686
SP  - 550
TI  - Progress towards antibiotic use targets in eight high-income countries
T2  - Bulletin of the World Health Organization
UR  - http://dx.doi.org/10.2471/blt.20.270934
UR  - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319863/pdf/BLT.20.270934.pdf
UR  - http://hdl.handle.net/10044/1/89186
VL  - 99
ER  -
Download